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I  A bstract
Introduction and Objective : Dental caries is an inflammatory disease with multifactorial etiology. The presented study was 
conducted to test the hypothesis that the elevation of salivary cytokines -  interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour 
necrosis factor (TNF-a ) is changed in dental caries patients. IL-6, IL-8 and TNF-a  are particularly relevant to inflammation, 
one of the very first responses of the host to a pathological insult.
Materials and Methods : Whole saliva from 26 patients with dental caries, as well as 10 healthy persons, was investigated 
for the presence of IL-6, IL-8 and TNF-a  by enzyme immunoassay -  ELISA.
Results: The results showed that an elevation of IL-6, IL-8 and TNF-a  in unstimulated whole saliva in subjects with dental 
caries, compared with controls, increased and was statistically significant in all cases (p <0.05). The study also show a positive 
correlation between TNF-a  and IL-8.
Conclusions: These data suggest links between the production of tumour necrosis factor (TNF-a ), interleukin-6 (IL-6), 
interleukin-8 (IL-8) in saliva and dental caries disease.
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INTRODUCTION
Dental caries is an infectious disease with multifactorial 
etiology [1]. A large number of research studies have been 
carried out to discover the cause of this disease. The process 
of dental caries is now well understood and is determined by 
a dynamic balance between pathological factors (acidogenic 
bacteria, reduced salivary function) and protective factors 
(proteins, fluoride, calcium, phosphate) [2]. It is also well 
know n that saliva secretion and salivary components 
are im portant for dental health. Inorganic and organic 
components in saliva may influence the colonization and 
elimination of microorganisms from the oral cavity [3, 4]. 
Bacteria colonize the oral cavity and lead to the process of 
inflammation. These lesions induce both innate and adaptive 
im m une responses by the host [2]. The predom inant cell 
types within periapical lesions are neutrophils, macrophages, 
T- and B-lymphocytes, mast cells, osteoclasts, osteoblasts, 
and fibroblasts. These cells express a large num ber of 
proinflam m atory cytokines, including interleukin IL-6, 
IL-4, IL-1-b, IL-1-a, tum our necrosis factor (TNF-a), and 
lym photoxin-a [5, 6]. These cytokines are likely released 
into the systemic circulation, since animal models indicate 
that proinflammatory cytokine concentrations are higher 
w ithin the serum  of animals with periapical lesions. The
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concentrations of proinflam m atory cytokines are also 
elevated w ithin bo th  the serum  and gingival tissues of 
persons with periodontal inflammation, and may contribute 
to a systemic hyperinflammatory state, which is a risk factor 
for several types of systemic diseases [7].
The role of T N F -a  in host defence and inflam m atory 
responses is well documented [8, 9]. TN F-a is reported to 
prom ote the inflam m atory cell infiltration by leukocyte 
adhesion molecules on endothelial cells and activate 
phagocyte killing mechanisms. TN F-a is a proinflammatory 
cytokine that was originally discovered as a protein with 
necrotizing effects in certain transplantable mouse tumors, 
and is now recognized as a cytokine w ith pleiotropic 
biological capacities. Besides its cytostatic and cytotoxic 
effects on certain tum our cells, TN F-a influences growth, 
differentiation, and/or the function of virtually every cell 
type investigated. Moreover, T N F-a is thought to be part of 
an integral network of interactive signals that orchestrate 
inflammatory and immunological events [8, 9].
IL-6 is a m ultifunctional cytokine playing a central role 
in inflammation and tissue injury [10]. Its levels positively 
correlate with higher all-cause mortality, unstable angina, 
propensity to diabetes and its complications, hypertension, 
and obesity. Moreover, proinflam m atory cytokines were 
revealed to be sensitive systemic markers of tissue damage, 
and predictive of future adverse cardiac events among 
apparently healthy men. IL-6 and TN F-a levels have been 
shown in periapical lesions and in the liver of rats with 
induced periapical abscesses [10].
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IL-6 and TNF-a are two cytokines traditionally considered 
to be key mediators of acute inammation [9, 11]. Both factors 
are also crucial for the development of specic immune 
responses, as mice lacking IL-6 or TNF-a gene expression 
are decient in T and B cell function. Inammation and 
immune induction can be viewed as intimately linked 
events as the successful resolution of the inammatory 
process leads to the transition from innate to adaptive 
immunity. Of the two cytokines, IL-6 in particular – through 
dierential control of leukocyte recruitment, activation and 
apoptosis – has emerged as one of a network of mediators 
directing this shi from innate to specic immunity [11]. 
Importantly, IL-6 has also been implicated in the regulation 
of lymphocyte tracking through the lymph node following 
an inammatory stimulus [11].
Cytokines like TNF-a and IL-1 are strong inducers of 
interleukin-8 (IL-8). IL-8 is an inammatory and chemotaxis 
factor belonging to the CXC family of proteins with glutamate-
leucine-arginine (ELR) motif near the N-terminus of the 
molecule. IL-8 activates multiple intracellular signalling 
pathways downstream of two cell-surface receptors CXCR-1 
and CXCR-2 [12]. IL-8 is synthesized by a vast number of 
dierent cells, including monocytes, macrophages, T-cells, 
neutrophils, broblasts, endothelial cells and chondrocytes. 
e main function of IL-8 is to attract neutrophils and 
activate them [13, 14, 15, 16]. IL-8 has been shown to play 
an important role in tumour growth, angiogenesis and 
metastasis [17].
ere are known research works about the concentration 
of pro-inammatory cytokines in saliva in oral lichen planus, 
aphthous stomatitis, periodontitis, squamous cell carcinoma 
patients, and control groups [18, 19, 20, 21]. ere is no data 
about the concentration of IL-6, IL-8 and TNF-a in saliva in 
dental caries patients. e aim of this study was to compare 
the concentration of pro-inammatory cytokines IL-6, IL-8 
and TNF-a in the saliva of dental caries patients with control 
group, and nd a correlation between cytokines.
MATERIALS AND METHODS
Study Population. 274 youths aged 18 suering from 
dental caries were recruited and served as an experimental 
group, 27 of whom were selected to determine levels of 
cytokines. 10 healthy subjects, also aged 18, served as the 
control group. Clinical evaluation procedures included: 
examination of teeth, periodontal, oral mucosal status, 
evaluation of malocclusion and collection of saliva samples. 
Body weight and height were measured using an electronic 
scale (Seca) and Holtain anthropometer. e results were 
compared with the updated national reference, and Body 
Mass Index (BMI) was calculated for each individual in a 
standard way.
e research protocol was approved by the Committee for 
Ethics and Supervision on Human and Animal Research, 
Medical University of Bialystok, with informed consent from 
the patients.
Dentistry criteria. Dental examination was performed 
in a school surgery using a dental mirror, a probe, and a 
periodontal probe in the articial light. e numbers of 
decayed teeth (D), missing teeth due to caries (M) and lled 
teeth (F) were evaluated in the dentition [22]. e facial 
features and occlusal conditions regarding the three planes, 
median, orbital and horizontal, were estimated by means of 
orthodontic diagnostics. e depth of gingival pouches and 
gingival haemorrhage were examined with a periodontal 
probe in individual sites in the teeth. Additionally, dental 
plaque and lesions on the mucus membrane of the oral cavity 
were evaluated.
Salivary Sample Collection. Saliva was collected by a 
standard method. Samples from the subjects were collected 
between 09:00-11:00. All subjects abstained from eating and 
drinking for 2 h. Unstimulated whole saliva was collected 
for 10 min by the spitting method. Saliva samples were 
homogenized and claried by centrifugation at 10,000 g for 
15 min at 4 °C. e aliquots of claried supernatants were 
stored at -70 °C for future use in cytokines measurements.
Detection of Salivary Levels of IL-6, IL-8 and TNF-α. 
Concentration of IL-6, IL-8 and TNF-a was determined in 
saliva of patients with dental caries and in control group. 
Aer collecting all the salivary samples, the studied cytokines 
were assessed by ELISA.
Determination of IL-6 in Salivary Samples. Saliva 
samples were determined by using an enzyme-linked 
immunosorbent assay kit (R&D Systems Inc., Minneapolis, 
MN, USA). A monoclonal mouse antibody specic for IL-6 
was pre-coated onto a microplate. Standards and samples 
(100 mL each) were pipetted into the wells in duplicate and any 
IL-6 present was bound by the immobilized antibody. e 
microplate was incubated for 2 h at room temperature. Aer 
washing away any unbound substances, an enzyme-linked 
polyclonal antibody-enzyme specic for IL-6 (200 mL) was 
added to each well for 2 h at room temperature. Following 
a wash to remove any unbound antibody enzyme-reagent, 
a substrate solution (200 mL) was added to the wells for 
20 min; the colour developed in proportion to the amount 
of IL-6 bound in the initial step. Colour development was 
stopped by sulphuric acid, and the intensity of the colour 
measured by measuring the absorbance at 450 nm. e 
minimum detectable dose (MDD) of IL-6 was 0.7 pg/mL. 
e concentrations of the samples were calculated from the 
standard curve and ranged from 0-300 pg/mL. e results 
were presented in picogram per mililiter (pg/mL). ere was 
no cross-reactivity with other cytokines.
Determination of IL-8 in Salivary Samples. Saliva 
samples were determined by using an enzyme-linked 
immunosorbent assay kit (R&D Systems Inc., Minneapolis, 
MN, USA). A monoclonal mouse antibody specic for IL-8 
was pre-coated onto a microplate. Standards and samples 
(50 mL each) were pipetted into the wells in duplicate, and 
any IL-8 present was bound by the immobilized antibody. 
e samples were diluted and the microplate incubated for 
2 h at room temperature. Aer washing away any unbound 
substances, an enzyme-linked polyclonal antibody-enzyme 
specic for IL-8 (100 mL) was added to each of the wells for 
1 h at room temperature. Following a wash to remove any 
unbound antibody enzyme-reagent, a substrate solution 
(200 mL) was added to the wells for 30 min; colour developed 
in proportion to the amount of IL-8 bound in the initial 
step. Colour development was stopped by sulphuric acid 
and the intensity of the colour measured by measuring 
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the absorbance at 450 nm. e concentration of IL-8 was 
multiplied by the dilution factor. e minimum detectable 
dose (MDD) of IL-8 was 3.5 pg/mL. Concentrations of the 
samples were calculated from the standard curve and ranged 
from 0-2000 pg/mL. e results were presented in picogram 
per mililiter (pg/mL). ere was no cross-reactivity with 
other cytokines.
Determination of TNF-a in Salivary Samples. 
Concentration of TNF-a was determined by using a 
commercially available enzyme-linked immunosorbent 
assay kit (R&D Systems Inc., Minneapolis, MN, USA). 
A monoclonal mouse antibody specic for TNF-a was 
precoated onto a microplate. Standards and samples (200 mL 
each) were pipetted into the wells in duplicate, and any 
TNF-a present was bound by the immobilized antibody. e 
microplate was incubated for 2 h at room temperature. Aer 
washing away any unbound substances, an enzyme-linked 
polyclonal antibody-enzyme specic for TNF-a (200 mL) 
was added to each of the wells for 2 h at room temperature. 
Following a wash to remove any unbound antibody enzyme- 
reagent, a substrate solution (200 mL) was added to the wells 
for 20 min; colour developed in proportion to the amount 
of TNF-a bound in the initial step. e colour development 
was stopped by sulphuric acid, and the intensity of the colour 
was measured by measuring the absorbance at 450 nm. e 
minimum detectable dose (MDD) of TNF-a was 1.6 pg/mL. 
e concentrations of the samples were calculated from the 
standard curve and ranged from 0-500 pg/mL. e results 
were presented in picogram per mililiter (pg/mL). ere was 
no cross-reactivity with other cytokines.
Statistical Analysis. Results were expressed as mean ± 
standard deviation (SD). e Mann Whitney U test was 
performed to demonstrate the dierence of each cytokine 
level between dental caries patients and the control group 
in saliva. A statistically signicant dierence was dened at 
p < 0.05. All data was processed with Statistica 8.0 (StatSo, 
USA).
RESULTS
In dentistry, caries and its intensity in the dentition are 
dened using the caries intensity index of DMF (decay/
missing/lled; D+M+F/number of the examined). In the 
study group, the mean DMF was 11.33, which indicates a 
high caries rate of the adolescents examined. Gingivatis, 
according to the gingival index in the Loe evaluation [23], 
was estimated as marginal gingivitis both in the control and 
study group. e index was not higher than the clinically 
signicant value 1 (Tab. 1).
e mean BMI and diet between the control and 
experimental groups were comparable. e mean value of 
BMI was 22.12 ± 4.59 in control group, and 21.39 ± 9.05 in 
dental caries patients, is was not statistically signicant 
(p= 0.387) (Fig. 1).
e snacks most frequently consumed in both groups 
(Tab. 2), were: fruit (70.0% vs. 78.1%), yoghurts (50.0% vs. 
62.4%), sweets (60.0% vs. 62.8%), sandwiches (70.0% vs. 
57.3%), sweet buns, cakes, doughnuts (20.0% vs. 46.0%), fast 
food meals (10.0% vs. 17.5%), respectively (multiple choice 
answer).
Among the preferred beverages were: juice and fruit drinks 
(40.0% vs. 31.0%), sweetened, non-carbonated drinks (30.0% 
vs. 31.2%) sweetened carbonated beverages, such as cola type 
drinks and orangeade (30.0% vs. 28.8%) in the compared 
groups, respectively. Additionally, 30.0% of young people in 
the control group and as many as 47.5% of the study group 
declared that they added extra sugar to their drinks and 
meals (Tab. 3).
Table 1. Clinical prole of the study population
Groups N Mean SD p
DMF
Control  10 6.7 5.29
0.002**Experimental 274 11.33 3.85
All 284 11.17 3.99
GI
Control  10 0.24 0.33
0.733Experimental 274 0.3 0.41
All 284 0.3 0.41
PI
Control  10 0.42 0.33
0.919Experimental 274 0.53 0.61
All 284 0.52 0.6
**p < 0.05 – Dierences between patients with dental caries and healthy group.
DMF – decay/missing/lled index; PI – plaque index; GI – gingival index.
Control group Dental caries patients
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Figure 1. BMI measured in kg/m2 in control subjects, compared with levels in 
dental caries patients
Table 2. Characteristic of diet-snacking
Snacking Control group
N=10
Dental caries patients
N=274
p
n % n %
Fruit 7 70.0 214 78.1 0.543
Joghurts 5 50.0 171 62.4 0.426
Sweets 6 60.0 172 62.8 0.858
Sandwiches 7 70.0 157 57.3 0.423
Sweet buns, cakes, doughnuts 2 20.0 126 46.0 0.104
Fast food 1 10.0  48 17.5 0.535
Table 3. Characteristic of beverages
Types of beverages Control group
N=10
Dental caries patients
N=274
p
n % n %
Fruit juices and fruit drinks 4 40.0 85 31.0 0.546
Sweetened carbonated 
beverages
3 30.0 87 31.2 0.907
Sweetened zzy drinks 3 30.0 79 28.8 0.936
Additionally sweetened drinks 
and meals
3 30.0 130 47.5 0.276
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e presented study indicated a high consumption of 
sweets and sweetened beverages in the study group. As many 
as 36.5% of the study respondents consumed sweets every 
day, 38.4% – several times a day, 19.3% – several times a 
month, while only 5.8% consumed no sweets at all. In the 
control group, 10.0%, admitted that they ate sweets every day, 
70.0% – several times a week, 10.0% – several times a month, 
whereas 10.0% of respondents declared they had given up 
eating sweets (Tab. 4).
In the study group, only 34.3% reported they did not 
consume fast food, whereas 54.0% ate it several times a 
month, and 11.7% several times a week. In the control group, 
60.0% did not eat this type of food and 40.0% ate fast food 
several times a month (Tab. 5).
e levels of IL-6, IL-8 and TNF-a increased statistically 
in the dental caries group, more so than those in the 
controls. e highest signicance (p = 0.002) was observed 
when TNF-a in saliva was compared to its corresponding 
control group (Tab. 6). e mean level of salivary IL-6 was 
18.5 pg/mL (range: 0.68-107) in dental caries patients and 
2.68 pg/mL (range: 0.6-17.3) in the control group (Fig. 2). 
Statistically, salivary IL-6 levels were signicantly higher in 
dental caries patients (p=0.005) (Tab. 6). e mean level of 
salivary IL-8 was 1,489.24 pg/mL (range:198.18-3,405.21) in 
dental caries patients, and 619.19 pg/mL (range: 250-1,144) 
in the control group (Fig. 3). Statistically, salivary IL-8 levels 
were signicantly higher in dental caries patients (p=0.008) 
(Tab. 6). e mean level of salivary TNF-a was 36.5 pg/mL 
(range: 0.88-216) in dental caries patients, and 7.32 pg/mL 
(range: 2-23.1) in the control group (Fig. 4). Statistically, 
salivary TNF-a levels were signicantly higher in dental 
caries patients (p=0.002) (Tab. 6).
e correlation between IL-8 and TNF-a was positive and 
statistically signicant p= 0.009. ere was no signicant 
correlation between cytokines and dentistry parameters (Tab. 7).
Table 4. Frequency of consumption (sweets and sweetened beverages)
Consumption of sweets and 
sweetened beverages
Control group
N=10
Dental caries patients
N=274
p
n % n %
Every day 1 10.0 100 36.5 0.084
Several times a week 7 70.0 105 38.4 0.043**
Several times a month 1 10.0  53 19.3 0.458
No consumption 1 10.0  16  5.8 0.585
**p < 0.05 – Dierences between patients with dental caries and healthy group.
Table 5. Frequency of consumption (fast food)
Consumption of fast 
food
Control group
N=10
Dental caries patients
N=274
p
n % n %
Several times a week 0 - 32 11.7 0.250
Several times a month 4 40.0 148 54.0 0.381
No consumption 6 60.0 94 34.3 0.094
Table 6. Change in IL-6, IL-8 and TNF-a salivary levels in dental caries 
patients and control
Cytokines Control group
(n = 10)
Dental caries patients
(n = 26)
p
value
IL-6 (mean ± SD) 2.68 ± 5.51 18.50 ± 27.72 < 0.005**
IL-8 (mean ± SD) 619.19 ± 311.79 1489.24 ± 960.32 <0.008**
TNF-a (mean ± SD) 7.32 ± 6.98 36.50 ± 41.46 <0.002**
** p< 0.05 – Dierences between patients with dental caries and healthy group.
Control group Dental caries patients
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Figure 2. Salivary levels of IL-6 measured in pg/mL in control subjects, compared 
with levels in dental caries patients
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Figure 3. Salivary levels of IL-8 measured in pg/mL in control subjects, compared 
with levels in dental caries patients
Figure 4. Salivary levels of TNF – a measured in pg/mL in control subjects, compared 
with levels in dental caries patients
Table 7. Correlation between cytokines and correlation between 
dentistry parameters and cytokines in dental caries patients
Parameters DMF GI PI IL-6 IL-8 TNF-a
IL-6 0.142 0.156 0.149 0.784 0.295
IL-8 0.285 0.352 0.255 0.784 0.009**
TNF-a 0.675 0.770 0.341 0.295 0.009**
** p<0.05 – Dierences between patients with dental caries and healthy group.
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DISCUSSION
Dental caries is initiated by a bacterial biolm on the 
surface of the teeth, below the gingival margin. ere are 
dierent predisposing factors and aetiologies of this erosive 
condition. Chemical, biological and behavioural factors are 
crucial and help explain how some individuals exhibit more 
erosion than others. Several studies have shown the erosive 
potential of acidic drinks and foodstu [25].
A high consumption of high calorie sweets and sweet 
beverages was revealed, especially, in the study group. 
Although these products provide a sense of being full, they 
do provide the organism with an appropriate amount of 
nutrients. ey are high in calories and have a low nutritional 
value. Simple sugars, found in sweets, are the best substrate 
for caries- forming bacteria, which by means of enzymatic 
conversion, produce acids which demineralize dental hard 
tissue [26]. e frequent consumption of sweetened, non-
carbonated and carbonated drinks, including drinks of 
the Cola type, is of great importance. Coca-cola has potent 
erosive properties, and due to its acidic content, leads to 
enamel erosion when consumed frequently and for a long 
period of time [27, 28].
e damaged dental structure becomes the site prone 
to the development of caries. e constant increase in the 
concentration of sugars provided in food results in adaptive 
changes of bacteria in the dental plaque. Bacteria become 
more acid-resistant and acid- forming, even several-fold, 
which constitutes the high caries-forming factor. Until fairly 
recently it was assumed that the bacteria were the primary 
cause of tissue destruction; however, a large body of research 
has revealed that it is the patient’s immune response that is 
actually responsible for the majority of the breakdowns of 
tooth-supporting tissues.
e purpose of therapy is to restore the balance of pro-
inammatory or destructive mediators and anti-inammatory 
or protective mediators to that seen in healthy individuals 
[2]. More information is needed about the molecular 
mechanisms connected with dental caries. It is known that 
pro-inammatory cytokines play role in such a mechanism, 
but the details remain unexplained. Cytokines, with other 
factors, will be useful tools for diagnosis and monitoring 
the oral cavity, and saliva could be used as a non-invasive 
diagnostic uid to measure biomarkers released during 
disease initiation and progression. Cytokines regulate many 
aspects of the immune response. In leukocyte tracking, 
cytokines have been shown to inuence the expression of 
adhesion markers and, quite possibly, associated chemokines. 
In the innate response, oral microbial pathogen-associated 
molecular patterns bind to pattern-recognition receptors on 
host cells, including dendritic cells, which then activate the 
inammatory response with a release of pro-inammatory 
cytokines, such as IL-1b, IL-6, IL-8, and TNF-a. Initially, 
only gingivitis might develop, and if the immune response is 
successful, the gingivitis will resolve; however, if the infection 
persists and further proliferation of the bacteria occurs, 
intensication of the inammatory response can lead to 
the destruction of periodontal tissue in susceptible subjects.
e presented study was undertaken to test the hypothesis 
that the elevation of salivary pro-inammatory cytokines – 
IL-6, TNF-a and chemokine – IL-8, changed in dental caries 
patients. TNF-a is known to be produced predominantly by 
activated macrophages at the site of infection/inammation, 
and also by T cells. IL-6, on the other hand, can be generated 
not only by activated macrophages/monocytes, but also by 
broblasts and activated endothelial cells in inamed tissue. 
In turn, IL-6 production can lead to the inhibition of TNF-a 
expression [11].
e obtained results show that the elevation of IL-6, 
IL-8 and TNF-a in unstimulated whole saliva in subjects 
with dental caries, compared with controls, increased and 
was statistically signicant in all cases (p <0.05). It is well 
known that the salivary level of cytokines may be increased 
as a result of disorders in the oral cavity. Researchers have 
speculated that dysfunction of the triangle oral mucosa, 
immune cells and saliva leads to the onset of oral mucosa 
diseases and inammation, such as oral lichen planus, oral 
cancer, periodontitis and leukoplakia [28].
TNF-a, IL-6 and IL-8 products of immune cells also play 
an important role in diseases of the oral mucosa, but the exact 
role played by cytokines in the aetiology of dental caries is 
not well known. e higher level of TNF-a was measured 
in patients with some inammatory diseases: oral lichen 
planus (OLP), aphtous stomatitis (RAS), oral squamous cell 
carcinoma (OSCC). e results were statistically signicant 
in OLP and RAS patients, but was not statistically signicant 
in OSCC patients [18, 19, 20, 21]. Researchers have found 
higher concentration of IL-6 in OSCC [19]. e levels of 
inammatory cytokine (IL-6, 8 and TNF-a) were determined 
in saliva in chronic periodontitis and periodontally healthy 
subjects. e level of IL-6 and TNF-a was higher, but IL-8 
lower, in a periodontally healthy group in comparison with 
chronic periodontitis [29].
ere are also some research studies that show lower 
concentrations of pro-inammatory cytokines aer dierent 
therapies. Ghallab showed a lower elevation of TNF-a in 
erosive OLP patients aer treatment with prednisone [21].
Higher levels of TNF-a and IL-6 in dental caries patients 
lead to a lower number of osteoblasts and broblasts, and 
they support the demineralization of teeth and development 
of the dental caries process [30]. IL-6, with other factors, 
causes the resorption of bones and stimulates the synthesis 
of chemocines [31]. Tani-Ischii et al. proved that TNF-a, 
which is locally produced by osteoclasts, is a very important 
factor regulating dierentiation of these cells and takes part 
in the processes of resorption [32].
e presented study shows the positive correlation between 
TNF-a and IL-8. TNF-a is an eector cytokine and its 
production leads to oral diseases [28]. It is probable that the 
higher level of IL-8 induces TNF-a. ese two cytokines 
play an important role in immunity of the oral cavity. Taken 
together, these data suggest links between the production 
of inammatory and immunoregulatory cytokines and 
chemokines, such as the tumour necrosis factor a (TNF-a), 
interleukin-6 (IL-6), interleukin-8 (IL-8), and dental caries 
disease.
CONCLUSIONS
e presented data are based on very small group and the 
ndings require further investigation. e results suggest 
links between the production of tumour necrosis factor a 
(TNF-a), interleukin-6 (IL-6), interleukin-8 (IL-8) in saliva 
and dental caries disease. Tumour necrosis factor a (TNF-a), 
interleukin-6 (IL-6) and interleukin-8 (IL-8) secretion in 
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saliva will be useful tools for diagnosing and monitoring 
dental caries disease, and saliva could be used as a non-
invasive diagnostic uid to measure biomarkers released 
during disease initiation and progression.
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